270 related articles for article (PubMed ID: 35201897)
1. Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes.
Fisher K; Wang XQ; Lee A; Morcilla V; de Vries A; Lee E; Eden JS; Deeks SG; Kelleher AD; Palmer S
J Virol; 2022 Mar; 96(6):e0201121. PubMed ID: 35201897
[TBL] [Abstract][Full Text] [Related]
2. Intact HIV Proviruses Persist in Children Seven to Nine Years after Initiation of Antiretroviral Therapy in the First Year of Life.
Katusiime MG; Halvas EK; Wright I; Joseph K; Bale MJ; Kirby-McCullough B; Engelbrecht S; Shao W; Hu WS; Cotton MF; Mellors JW; Kearney MF; van Zyl GU
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776265
[TBL] [Abstract][Full Text] [Related]
3. Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells.
Hendricks CM; Cash MN; Tagliamonte MS; Riva A; Brander C; Llano A; Salemi M; Stevenson M; Mavian C
Microbiol Spectr; 2022 Aug; 10(4):e0135322. PubMed ID: 35699458
[TBL] [Abstract][Full Text] [Related]
4. Impact of Antiretroviral Therapy Duration on HIV-1 Infection of T Cells within Anatomic Sites.
Lee E; von Stockenstrom S; Morcilla V; Odevall L; Hiener B; Shao W; Hartogensis W; Bacchetti P; Milush J; Liegler T; Sinclair E; Hatano H; Hoh R; Somsouk M; Hunt P; Boritz E; Douek D; Fromentin R; Chomont N; Deeks SG; Hecht FM; Palmer S
J Virol; 2020 Jan; 94(3):. PubMed ID: 31723024
[TBL] [Abstract][Full Text] [Related]
5. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.
Kearney MF; Wiegand A; Shao W; Coffin JM; Mellors JW; Lederman M; Gandhi RT; Keele BF; Li JZ
J Virol; 2016 Feb; 90(3):1369-76. PubMed ID: 26581989
[TBL] [Abstract][Full Text] [Related]
6. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy.
Omondi FH; Sudderuddin H; Shahid A; Kinloch NN; Jones BR; Miller RL; Tsai O; MacMillan D; Trocha A; Brockman MA; Brumme CJ; Joy JB; Liang R; Walker BD; Brumme ZL
mBio; 2021 Dec; 12(6):e0249021. PubMed ID: 34781741
[TBL] [Abstract][Full Text] [Related]
7. In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control.
Trémeaux P; Lemoine F; Mélard A; Gousset M; Boufassa F; Orr S; Monceaux V; Gascuel O; Lambotte O; Hocqueloux L; Saez-Cirion A; Rouzioux C; Avettand-Fenoel V
Microbiol Spectr; 2023 Feb; 11(1):e0326722. PubMed ID: 36692300
[TBL] [Abstract][Full Text] [Related]
8. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time.
Shahid A; MacLennan S; Jones BR; Sudderuddin H; Dang Z; Cobarrubias K; Duncan MC; Kinloch NN; Dapp MJ; Archin NM; Fischl MA; Ofotokun I; Adimora A; Gange S; Aouizerat B; Kuniholm MH; Kassaye S; Mullins JI; Goldstein H; Joy JB; Anastos K; Brumme ZL;
J Virol; 2024 Feb; 98(2):e0165523. PubMed ID: 38214547
[TBL] [Abstract][Full Text] [Related]
9. HIV RNA Rebound in Seminal Plasma after Antiretroviral Treatment Interruption.
Gianella S; Chaillon A; Chun TW; Sneller MC; Ignacio C; Vargas-Meneses MV; Caballero G; Ellis RJ; Kovacs C; Benko E; Huibner S; Kaul R
J Virol; 2020 Jul; 94(15):. PubMed ID: 32434884
[TBL] [Abstract][Full Text] [Related]
10. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
Aamer HA; McClure J; Ko D; Maenza J; Collier AC; Coombs RW; Mullins JI; Frenkel LM
PLoS Pathog; 2020 Aug; 16(8):e1008791. PubMed ID: 32841299
[TBL] [Abstract][Full Text] [Related]
11. Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations.
Winckelmann A; Barton K; Hiener B; Schlub TE; Shao W; Rasmussen TA; Østergaard L; Søgaard OS; Tolstrup M; Palmer S
AIDS; 2017 Mar; 31(6):771-779. PubMed ID: 28272134
[TBL] [Abstract][Full Text] [Related]
12. Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption.
Cole B; Lambrechts L; Boyer Z; Noppe Y; De Scheerder MA; Eden JS; Vrancken B; Schlub TE; McLaughlin S; Frenkel LM; Palmer S; Vandekerckhove L
Cell Rep; 2022 Apr; 39(4):110739. PubMed ID: 35476994
[TBL] [Abstract][Full Text] [Related]
13. Deep Sequencing Analysis of Individual HIV-1 Proviruses Reveals Frequent Asymmetric Long Terminal Repeats.
Joseph KW; Halvas EK; Brandt LD; Patro SC; Rausch JW; Chopra A; Mallal S; Kearney MF; Coffin JM; Mellors JW
J Virol; 2022 Jul; 96(13):e0012222. PubMed ID: 35674431
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning of full-length HIV-1 genomes directly from plasma viral RNA.
Fang G; Weiser B; Visosky AA; Townsend L; Burger H
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(4):352-7. PubMed ID: 8673543
[TBL] [Abstract][Full Text] [Related]
15. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
[TBL] [Abstract][Full Text] [Related]
16. Combined HIV-1 sequence and integration site analysis informs viral dynamics and allows reconstruction of replicating viral ancestors.
Patro SC; Brandt LD; Bale MJ; Halvas EK; Joseph KW; Shao W; Wu X; Guo S; Murrell B; Wiegand A; Spindler J; Raley C; Hautman C; Sobolewski M; Fennessey CM; Hu WS; Luke B; Hasson JM; Niyongabo A; Capoferri AA; Keele BF; Milush J; Hoh R; Deeks SG; Maldarelli F; Hughes SH; Coffin JM; Rausch JW; Mellors JW; Kearney MF
Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25891-25899. PubMed ID: 31776247
[TBL] [Abstract][Full Text] [Related]
17. Single-molecule techniques to quantify and genetically characterise persistent HIV.
Wang XQ; Palmer S
Retrovirology; 2018 Jan; 15(1):3. PubMed ID: 29316955
[TBL] [Abstract][Full Text] [Related]
18. Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor.
Salvi R; Garbuglia AR; Di Caro A; Pulciani S; Montella F; Benedetto A
J Virol; 1998 May; 72(5):3646-57. PubMed ID: 9557645
[TBL] [Abstract][Full Text] [Related]
19. Phylogenetic Analyses Comparing HIV Sequences from Plasma at Virologic Failure to Cervix Versus Blood Sequences from Antecedent Antiretroviral Therapy Suppression.
Bull ME; McKernan JL; Styrchak S; Kraft K; Hitti J; Cohn SE; Tapia K; Deng W; Holte S; Mullins JI; Coombs RW; Frenkel LM
AIDS Res Hum Retroviruses; 2019 Jun; 35(6):557-566. PubMed ID: 30892052
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
